Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Light Polymers is a nanochemistry company that develops proprietary lyotropic liquid crystal (LLC) technology for a wide range of applications, including displays, lighting, and life sciences. The company's platform enables the self-assembly of molecules into ordered structures, which can be used to create high-performance coatings, polarizers, and diagnostic sensors. In the healthcare sector, Light Polymers focuses on utilizing its LLC materials to develop highly sensitive and cost-effective biosensors and point-of-care diagnostic tools. Their technology allows for the direct coating of optical components, reducing manufacturing complexity and improving the efficiency of light-based diagnostic systems. Headquartered in South San Francisco, the company operates globally with R&D and manufacturing facilities in the US and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Light Polymers.